NR2E3 and retinitis pigmentosa: Contrary to aforementioned studies indicating the benefits of Nr2e3 suppression in retinitis pigmentosa, AAV8-mediated augmentation of Nr2e3 at P0 was reported to improve photoreceptor survival and ERG responses in mouse models of IRDs (Li et al., 2021).